|
Volumn 43, Issue 2, 2003, Pages 109-110
|
Consensus statement: Menstrual and contraceptive management in women with an intellectual disability
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTRADIOL;
ETONOGESTREL;
GESTAGEN;
GONADORELIN DERIVATIVE;
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
TRANEXAMIC ACID;
AMENORRHEA;
ARTICLE;
BONE DISEASE;
CALCIUM INTAKE;
CONTRACEPTION;
DRUG DELIVERY SYSTEM;
ENDOMETRIUM ABLATION;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FEMALE;
FUNCTIONAL ASSESSMENT;
HORMONAL CONTRACEPTION;
HORMONE SUBSTITUTION;
HUMAN;
HYSTERECTOMY;
INTELLECTUAL IMPAIRMENT;
LEGAL ASPECT;
MEDICAL ASSESSMENT;
MENSTRUATION DISORDER;
ORAL CONTRACEPTION;
OSTEOPOROSIS;
PATIENT EDUCATION;
PREGNANCY;
PRIORITY JOURNAL;
RISK FACTOR;
SELF CARE;
SEXUALITY;
VITAMIN BLOOD LEVEL;
CONTRACEPTION;
FEMALE;
HUMANS;
INFORMED CONSENT;
MENARCHE;
MENTAL RETARDATION;
|
EID: 0038025246
PISSN: 00048666
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0004-8666.2003.00046.x Document Type: Article |
Times cited : (33)
|
References (0)
|